Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Iterum Therapeutics plc - Ordinary Share
No Price
31.03.2026 15:38
Current Prices from Iterum Therapeutics plc - Ordinary Share
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
ITRM
USD
31.03.2026 15:38
0,04 USD
-
IEX
ITRM
USD
31.03.2026 15:10
0,04 USD
-
Company Profile for Iterum Therapeutics plc - Ordinary Share Share
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
